Electroencephalography Devices Market Share, Growth Forecast Global Industry Outlook 2023 – 2032

In 2021, the market for Electroencephalography Devices worldwide was worth $1.22 billion US dollars. AMR Group projects that the market will reach US$ 2.83 billion by 2031, growing at a CAGR of 12.9 percent between 2022 and 2031.

Industry Overview
Electroencephalography (EEG) devices are medical devices used to measure and record the electrical activity of the brain by placing electrodes on the scalp. The EEG device records the electrical signals generated by the neurons in the brain and displays them as a graph on a computer screen. These signals are used to diagnose and monitor various neurological conditions such as epilepsy, sleep disorders, brain tumors, and brain injuries. EEG devices consist of electrodes that are attached to the scalp and a recording device that captures the electrical signals. The electrodes are placed on specific areas of the scalp according to the type of test being conducted. The EEG test is a non-invasive and painless procedure that usually takes between 30 minutes to one hour to complete. EEG devices are widely used in hospitals, clinics, and research institutes for various applications such as diagnosis, monitoring, and research. EEG devices can also be used for brain-computer interfaces, where the electrical signals generated by the brain are used to control external devices such as prosthetic limbs or computers.

Recent advancements in EEG technology have led to the development of portable and wireless EEG devices, making it easier to conduct tests outside the hospital or clinic setting. Overall, EEG devices play a critical role in the diagnosis and treatment of various neurological conditions and are an important tool for neurologists, clinicians, and researchers.

Market Dynamics
The Electroencephalography (EEG) devices market is expected to experience significant growth in the coming years, driven by a variety of factors. Here are some of the key dynamics shaping the EEG devices market:
Increasing Prevalence of Neurological Disorders: The rising incidence of neurological disorders, such as epilepsy, dementia, and Parkinson’s disease, is expected to drive the demand for EEG devices. As the global population ages, the incidence of these conditions is expected to increase, which will further drive market growth.

Technological Advancements: The development of portable and wireless EEG devices is making it easier to conduct tests outside of traditional hospital or clinical settings, which is expected to expand the market for EEG devices. Additionally, the increasing use of EEG devices in brain-computer interface (BCI) applications is expected to create new growth opportunities in the market.

Growing Awareness and Demand for Non-Invasive Diagnostic Procedures: The increasing awareness about the benefits of non-invasive diagnostic procedures is expected to drive the demand for EEG devices. EEG tests are non-invasive and painless, which makes them an attractive option for patients who may be reluctant to undergo more invasive procedures.
Cost Concerns: The high cost of EEG devices is expected to remain a challenge for market growth. The cost of EEG devices and associated accessories can be a significant barrier for smaller clinics and hospitals with limited budgets.

Limited Access to Skilled Professionals: The shortage of skilled professionals trained in using EEG devices may also hinder market growth. The shortage of skilled personnel may limit the adoption of EEG devices, particularly in developing countries.

Overall, the EEG devices market is expected to experience steady growth in the coming years, driven by the increasing incidence of neurological disorders, advancements in technology, and growing demand for non-invasive diagnostic procedures. However, challenges such as cost concerns and limited access to skilled professionals may limit market growth to some extent.

COVID Impact
The COVID-19 pandemic has had a mixed impact on the Electroencephalography (EEG) devices market. Here are some of the key ways in which the pandemic has affected the market:
Delayed or Canceled Elective Procedures: The pandemic has led to the postponement or cancellation of many elective procedures, including EEG tests. This has had a negative impact on the demand for EEG devices, particularly during the early stages of the pandemic when many hospitals and clinics were overwhelmed with COVID-19 patients.
Increased Demand for EEG Devices in COVID-19 Patients: EEG tests have been used to monitor the neurological status of COVID-19 patients in intensive care units (ICUs). This has led to an increase in demand for EEG devices in some regions, particularly in areas where there have been high numbers of COVID-19 patients.
Supply Chain Disruptions: The pandemic has led to disruptions in global supply chains, which has impacted the availability of EEG devices and associated accessories. Manufacturers have faced challenges in sourcing components and raw materials, which has led to delays in production and delivery.
Telemedicine and Remote Monitoring: The pandemic has led to a greater adoption of telemedicine and remote monitoring technologies. This has created new opportunities for EEG devices that can be used for remote monitoring of patients in their homes or in outpatient settings.
Overall, the impact of COVID-19 on the EEG devices market has been mixed. While the pandemic has led to a decline in demand for EEG tests in some regions, it has also created new opportunities for EEG devices in the context of remote monitoring and telemedicine. As the pandemic continues to evolve, it is likely that the EEG devices market will continue to be impacted in a variety of ways.

Regional Trend
The Electroencephalography (EEG) devices market is segmented into several regions, including North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Here is a brief overview of the regional dynamics of the EEG devices market:
North America: North America is the largest market for EEG devices, due to the high incidence of neurological disorders and a well-established healthcare infrastructure. The market is dominated by the United States, which accounts for the majority of the revenue in the region.
Europe: Europe is another important market for EEG devices, with a well-established healthcare infrastructure and a high incidence of neurological disorders. The market is driven by countries such as Germany, France, and the United Kingdom.
Asia-Pacific: The Asia-Pacific region is expected to be the fastest-growing market for EEG devices, due to the increasing prevalence of neurological disorders and the growing healthcare infrastructure in the region. China, Japan, and India are the major markets in the region.
Latin America: The Latin America market for EEG devices is expected to grow at a moderate pace, driven by increasing awareness about the benefits of non-invasive diagnostic procedures and a growing demand for advanced medical technologies.
Middle East and Africa: The Middle East and Africa market for EEG devices is expected to grow at a steady pace, driven by increasing investments in healthcare infrastructure and a growing demand for advanced medical technologies.

Competitive Landscape
The competitive landscape of the Electroencephalography (EEG) devices market is highly fragmented, with several global and regional players competing for market share. The market is characterized by the presence of a large number of established players, as well as new entrants offering innovative products and technologies.

Some of the key players in the market include:
Nihon Kohden Corporation
Medtronic plc
Compumedics Limited
Koninklijke Philips N.V.
Cadwell Industries Inc.
Natus Medical Incorporated
Electrical Geodesics Inc.
NeuroWave Systems Inc.
Advanced Brain Monitoring Inc.
Bio-Signal Group Corp.

These companies compete on the basis of product quality, brand recognition, innovation, and pricing. They also invest heavily in research and development to bring new and innovative EEG devices to market. In addition, many of these companies have established distribution networks and partnerships with healthcare providers and institutions to increase their market share.

Mergers and acquisitions have also been a key strategy for many companies to expand their product portfolios and increase their market share. For example, in 2021, Nihon Kohden Corporation announced the acquisition of Cadwell Industries Inc. to expand its EEG and neurodiagnostic product portfolio.
Overall, the competitive landscape of the EEG devices market is highly competitive, with several players vying for market share through product innovation, partnerships, and mergers and acquisitions.

Market Segmentation
The Electroencephalography (EEG) devices market can be segmented based on various factors. Here are some of the common segmentation criteria:

Product type: EEG devices can be segmented into standalone devices, portable devices, and integrated devices.

Modality: EEG devices can be segmented based on the modality into routine EEG, sleep EEG, ambulatory EEG, and video EEG.

Application: EEG devices can be segmented based on application into clinical diagnostics, research, and others.

End-user: EEG devices can be segmented based on end-user into hospitals, diagnostic centers, research institutes, and others.

Each of these segments can provide valuable insights into the market trends and dynamics, helping stakeholders make informed decisions about their business strategies. For instance, the application-based segmentation can provide insights into the most profitable application areas for EEG devices, while the end-user segmentation can help manufacturers identify the key customer groups for their products.